REVIVA PHARMACEUTICALS HOLDINGS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Reviva Pharmaceuticals Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Reviva Pharmaceuticals Holdings, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 33.8M shares, a 43% increase year-over-year.
  • Reviva Pharmaceuticals Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 23.8M shares, a 21.9% increase from 2022.
  • Reviva Pharmaceuticals Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 19.5M shares, a 32% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 33.8M +10.2M +43% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 30.6M +8.12M +36.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 29.9M +8.05M +36.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 23.8M +4.28M +21.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 23.6M +4.37M +22.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 22.4M +3.97M +21.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 21.8M +3.37M +18.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 19.5M +4.73M +32% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 19.3M +814K +4.41% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 18.5M +5.59M +43.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 18.5M +9.23M +100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 14.8M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 18.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 12.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 9.23M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.